Protagonist Therapeutics, Inc PTGX
$155.10
+2.43%
at last close
Financials (TTM)
- Revenue
- $281.99 million
- Net Income
- $82.91 million
- Net Margin
- 29.40%
- Return on Equity
- 9.85%
- Debt-to-Equity
- —
- P/E Ratio
- 150.58
- Price / Book
- 11.69
- Price / Sales
- 34.88
Over the trailing twelve months, Protagonist Therapeutics, Inc generated revenue of $281.99 million and net income of $82.91 million, a net margin of 29.40%.
At the last closing price of $155.10, PTGX trades at 150.58 times trailing earnings and 34.88 times sales, with a market capitalization of $9.84 billion.
Key Stats
- Last Close
- $155.10
- Market Cap
- $9.84 billion
- 52-Week Range
- $50.48 – $155.53
- Average Volume
- 627K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.